Recently, RC001, RecoRNA’s independently developed drug candidate targeting specific neurological disease, was successfully granted for Orphan Drug Designation (ODD) by the U.S. Food and Drug Administ...
Recently, RC001, RecoRNA’s independe...
Recently, RC001, RecoRNA’s independe...